Tranilast Sodium is primarily used in the treatment of allergic conditions, particularly bronchial asthma and allergic rhinitis. It works by inhibiting the release of histamine and other inflammatory mediators from mast cells, thereby reducing allergic reactions and inflammation. Additionally, it is applied in the management of hypertrophic scars and keloids, where it helps to suppress excessive collagen deposition and fibrotic tissue formation. In dermatology, it is also utilized for its anti-inflammatory properties to treat conditions like atopic dermatitis. Furthermore, Tranilast Sodium has shown potential in research for its anti-fibrotic effects in various fibrotic diseases, including liver fibrosis and pulmonary fibrosis. Its ability to modulate immune responses makes it a valuable compound in both clinical and experimental settings for managing inflammatory and fibrotic disorders.